Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
XOMA Royalty Corp | Chief Executive Officer, Director | Performance Stock Units | 222K | $3.08M | $13.89 | Nov 11, 2024 | Direct |
XOMA Royalty Corp | Chief Executive Officer, Director | Common Stock | 35K | $1.05M | $29.95 | Nov 13, 2024 | Direct |
C4 Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 32.5K | Jun 20, 2024 | Direct | ||
PARDES BIOSCIENCES, INC. | Director | Class A Common Stock | 30K | Dec 23, 2021 | Direct | ||
Ikena Oncology, Inc. | Director | Stock Option (Right to Buy) | 17.5K | Jun 7, 2024 | Direct | ||
XOMA Royalty Corp | Chief Executive Officer, Director | Depositary Shares - 8.375% Series B Perpetual Preferred | 2K | Nov 11, 2024 | Direct | ||
PARDES BIOSCIENCES, INC. | Director | Class B Common Stock | 0 | Dec 23, 2021 | Direct | ||
Radius Health, Inc. | Director | Common Stock | 0 | $10.00 | Aug 15, 2022 | Direct | |
Radius Health, Inc. | Director | Stock Option (Right to Buy) | 0 | $4.16 | Aug 15, 2022 | Direct | |
Translate Bio, Inc. | Director | Common Stock | 0 | $38.00 | Sep 14, 2021 | Direct | |
Translate Bio, Inc. | Director | Stock Option (righ to buy) | 0 | Sep 14, 2021 | Direct | ||
Translate Bio, Inc. | Director | Stock Option (right to buy) | 0 | Sep 14, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XOMA | XOMA Royalty Corp | Nov 11, 2024 | 3 | -$655K | 4 | Nov 13, 2024 | Chief Executive Officer, Director |
CCCC | C4 Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
IKNA | Ikena Oncology, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
XOMA | XOMA Corp | Jan 8, 2024 | 1 | $0 | 4 | Jan 10, 2024 | Chief Executive Officer, Director |
CCCC | C4 Therapeutics, Inc. | Nov 16, 2023 | 1 | $0 | 4 | Nov 20, 2023 | Director |
CCCC | C4 Therapeutics, Inc. | Nov 16, 2023 | 0 | $0 | 3 | Nov 20, 2023 | Director |
XOMA | XOMA Corp | Oct 2, 2023 | 1 | $13.8K | 4 | Oct 4, 2023 | Exec Chairman and Interim CEO, Director |
XOMA | XOMA Corp | Sep 25, 2023 | 2 | $36.1K | 4 | Sep 27, 2023 | Exec Chairman and Interim CEO, Director |
IKNA | Ikena Oncology, Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
XOMA | XOMA Corp | May 23, 2023 | 3 | $47.3K | 4 | May 25, 2023 | Interim CEO, Director |
XOMA | XOMA Corp | Jan 3, 2023 | 2 | $0 | 4 | Jan 5, 2023 | Interim CEO, Director |
XOMA | XOMA Corp | Jan 1, 2023 | 0 | $0 | 3 | Jan 6, 2023 | Interim CEO, Director |
IKNA | Ikena Oncology, Inc. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director |
IKNA | Ikena Oncology, Inc. | Dec 14, 2022 | 0 | $0 | 3 | Dec 19, 2022 | Director |
RDUS | Radius Health, Inc. | Aug 15, 2022 | 3 | -$318K | 4 | Aug 15, 2022 | Director |
RDUS | Radius Health, Inc. | Jan 14, 2022 | 2 | $0 | 4 | Jan 25, 2022 | Director |
PRDS | PARDES BIOSCIENCES, INC. | Dec 23, 2021 | 2 | $0 | 4/A | Dec 30, 2021 | Director |
TBIO | Translate Bio, Inc. | Sep 14, 2021 | 5 | -$1.13M | 4 | Sep 14, 2021 | Director |
TBIO | Translate Bio, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |